Scientists think caffeine is responsible for these benefits
No, GLP-1 receptor agonists are not licensed or recommended for treating IBS
Food and Drug Administration (FDA), the most commonly reported side effects of these medications include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, bloating, belching, and flatulence
Toxicity study of 28-day subcutaneous injection of arctigenin in Beagle Dogs
Because it relies on the pituitary's own machinery, the GH release it produces follows the body's natural pulsing rhythm rather than overriding it
GLP-1 medications appear to have broader anti-inflammatory effects that span both type 1 and type 2 pathways, which may explain why patient reports of skin improvement on these medications include both psoriasis and eczema